Skip to main content
BrainCited
Figure 8. (A–E) The ROC curve of targets of curcumin against AD-related tau and aβ pathology. AD = Alzheimer disease, ROC = receiver operating characteristic.
Figure 9. Figure 8. (A–E) The ROC curve of targets of curcumin against AD-related tau and aβ pathology. AD = Alzheimer disease, ROC = receiver operating characteristic.

Cite This Figure

![Figure 9: Figure 8. (A–E) The ROC curve of targets of curcumin against AD-related tau and aβ pathology. AD = Alzheimer disease, ROC = receiver operating characteristic.](https://pdfs.citedhealth.com/figures/36042609/199.png)

> Source: Xinyan Wu et al. "A network pharmacology approach to identify the mechanisms and molecular targets." *Medicine*, 2022. PMID: [36042609](https://pubmed.ncbi.nlm.nih.gov/36042609/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/36042609/199.png" alt="Figure 8. (A–E) The ROC curve of targets of curcumin against AD-related tau and aβ pathology. AD = Alzheimer disease, ROC = receiver operating characteristic." />
  <figcaption>Figure 9. Figure 8. (A–E) The ROC curve of targets of curcumin against AD-related tau and aβ pathology. AD = Alzheimer disease, ROC = receiver operating characteristic.<br>  Source: Xinyan Wu et al. "A network pharmacology approach to identify the mechanisms and molecular targets." <em>Medicine</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36042609/">36042609</a></figcaption>
</figure>